[1]
Hussain, M. et al. 2024. EFFECT OF DAPAGLIFLOZIN AND EMPAGLIFLOZIN ON BODY WEIGHT, LIPID PROFILE AND BLOOD PRESSURE IN TYPE 2 DIABETICS. Pakistan Journal of Physiology. 20, 2 (Jun. 2024), 36–40. DOI:https://doi.org/10.69656/pjp.v20i2.1607.